Redbud NA1
Pathogen Nucleic Acid Extraction
Key Facts
About Redbud Labs
Redbud Labs is a private, commercial-stage company leveraging its proprietary microfluidics platform to create automated sample prep solutions, primarily for diagnostic and research applications. The company's lead commercial offering is the Redbud NA1, an automated nucleic acid extraction system, which positions it in the growing market for streamlined molecular workflows. With a leadership team experienced in microfluidics, diagnostics, and medical device commercialization, and backing from a distinguished scientific founder, the company is focused on making laboratory automation more accessible. Redbud Labs appears to be in an early revenue-generating phase, actively showcasing its NA1 platform at industry conferences to drive adoption.
View full company profile